Panel: AI in Pharma: Mastering Change to Lead in Tomorrow’s Market

AI has been a transformative force in the pharmaceutical industry for years, yet its true potential remains largely untapped. As the technology matures, the shift is moving from initial adoption to full integration—posing a critical question: Is the industry prepared to fully leverage AI’s capabilities? To stay competitive and realize AI’s benefits, pharma must address key challenges such as overcoming integration bottlenecks, defining measurable success, and accelerating innovation. From improving R&D efficiency to navigating commercialization, this session will explore how organizations can overcome obstacles and lead the charge in AI-driven transformation. What are the key obstacles, such as legacy systems, data silos, and resistance to change, that hinder the seamless integration of AI into existing pharmaceutical workflows and operations? How can AI accelerate more efficient research and development processes? What strategies, including regulatory compliance, market readiness, and partnership models, can AI help pharma companies successfully commercialize products and solutions in a competitive market?